Merck Keytruda cuts mortality risk in gastric cancer (NYSE:MRK)
JHVEPhoto Merck (NYSE:MRK) introduced Saturday that its anti-PD-1 remedy Keytruda (pembrolizumab) as a part of a mixture routine lowered the ...
Tag: Merck
Merck coformulation fails to meet key goal in lung cancer trial (NYSE:MRK)
Merck (NYSE:MRK) stated on Thursday that its investigational coformulation for metastatic non-small cell lung most cancers (NSCLC) didn't present an ...
Merck Stock Will Keep Your Retirement Income Healthy (NYSE:MRK)
Erik S. LesserIt may not be the sexiest enterprise of all -- researching, growing and promoting medical medication, nevertheless it ...
